company background image
NINH

Nozha International HospitalCASE:NINH Stock Report

Market Cap

ج.م995.6m

7D

-1.2%

1Y

63.7%

Updated

21 Oct, 2021

Data

Company Financials
NINH fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

NINH Overview

Nozha International Hospital provides various medical, diagnostic, and therapeutic services in Egypt.

Price History & Performance

Summary of all time highs, changes and price drops for Nozha International Hospital
Historical stock prices
Current Share Priceج.م9.44
52 Week Highج.م5.20
52 Week Lowج.م11.50
Beta0.40
1 Month Change-4.74%
3 Month Change-6.81%
1 Year Change63.66%
3 Year Change91.26%
5 Year Change163.81%
Change since IPO3,835.12%

Recent News & Updates

Shareholder Returns

NINHEG HealthcareEG Market
7D-1.2%1.3%-0.8%
1Y63.7%-14.9%11.1%

Return vs Industry: NINH exceeded the EG Healthcare industry which returned -16.1% over the past year.

Return vs Market: NINH exceeded the EG Market which returned 9.2% over the past year.

Price Volatility

Is NINH's price volatile compared to industry and market?
NINH volatility
NINH Beta0.40
Industry Beta0.39
Market Beta1

Stable Share Price: NINH is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: NINH's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985n/aMohammed Bayomy Somorhttps://www.nih.com.eg

Nozha International Hospital provides various medical, diagnostic, and therapeutic services in Egypt. The company offers endocrinology, kids, gynecology, nephrology, internal medicine, gastroenterology, kidney diseases, hematology, speech pathology, neurology, dental, balance tests, immunology, rheumatology, allergy, dermatology, genital and male diseases, general surgery, nutrition, obesity, thinness, diabetes, physiotherapy, orthopedic, psychiatric, audiology, ophthalmology, vascular surgery, plastic surgery, pediatric surgery, urology, heart, respiratory function, pacemakers, oncology, pain, elderly care, EEG, and nerve placement clinical medical services. Nozha International Hospital was founded in 1985 and is based in Cairo, Egypt.

Nozha International Hospital Fundamentals Summary

How do Nozha International Hospital's earnings and revenue compare to its market cap?
NINH fundamental statistics
Market Capج.م995.63m
Earnings (TTM)ج.م51.14m
Revenue (TTM)ج.م246.04m

19.5x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NINH income statement (TTM)
Revenueج.م246.04m
Cost of Revenueج.م166.13m
Gross Profitج.م79.91m
Expensesج.م28.77m
Earningsج.م51.14m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.48
Gross Margin32.48%
Net Profit Margin20.79%
Debt/Equity Ratio0.3%

How did NINH perform over the long term?

See historical performance and comparison

Valuation

Is Nozha International Hospital undervalued compared to its fair value and its price relative to the market?

19.47x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: NINH (EGP9.44) is trading above our estimate of fair value (EGP8.52)

Significantly Below Fair Value: NINH is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: NINH is good value based on its PE Ratio (19.5x) compared to the African Healthcare industry average (32.3x).

PE vs Market: NINH is poor value based on its PE Ratio (19.5x) compared to the EG market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NINH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NINH is overvalued based on its PB Ratio (3.4x) compared to the XF Healthcare industry average (2.8x).


Future Growth

How is Nozha International Hospital forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nozha International Hospital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Nozha International Hospital performed over the past 5 years?

13.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NINH has high quality earnings.

Growing Profit Margin: NINH's current net profit margins (20.8%) are lower than last year (24.4%).


Past Earnings Growth Analysis

Earnings Trend: NINH's earnings have grown by 13.3% per year over the past 5 years.

Accelerating Growth: NINH's earnings growth over the past year (4.5%) is below its 5-year average (13.3% per year).

Earnings vs Industry: NINH earnings growth over the past year (4.5%) underperformed the Healthcare industry 4.5%.


Return on Equity

High ROE: NINH's Return on Equity (19.8%) is considered low.


Financial Health

How is Nozha International Hospital's financial position?


Financial Position Analysis

Short Term Liabilities: NINH's short term assets (EGP247.3M) exceed its short term liabilities (EGP47.5M).

Long Term Liabilities: NINH's short term assets (EGP247.3M) exceed its long term liabilities (EGP2.7M).


Debt to Equity History and Analysis

Debt Level: NINH's debt to equity ratio (0.3%) is considered satisfactory.

Reducing Debt: NINH's debt to equity ratio has reduced from 0.3% to 0.3% over the past 5 years.

Debt Coverage: NINH's debt is well covered by operating cash flow (9003.1%).

Interest Coverage: NINH earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Nozha International Hospital current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NINH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NINH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NINH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NINH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: NINH is not paying a notable dividend for the EG market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NINH's dividend in 3 years as they are not forecast to pay a notable one for the EG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Mohammed Bayomy Somor

no data

Tenure

Dr. Mohammed Bayomy Hasan Somor serves as the Chairman and Managing Director at Nozha International Hospital.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Nozha International Hospital's employee growth, exchange listings and data sources


Key Information

  • Name: Nozha International Hospital
  • Ticker: NINH
  • Exchange: CASE
  • Founded: 1985
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ج.م995.625m
  • Shares outstanding: 105.47m
  • Website: https://www.nih.com.eg

Location

  • Nozha International Hospital
  • 9 El Rashidy Street
  • Masaken Sheraton
  • Cairo
  • Egypt

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/21 14:31
End of Day Share Price2021/10/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.